<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Med Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur. J. Med. Res</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Medical Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0949-2321</issn>
      <issn pub-type="epub">2047-783X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25416032</article-id>
      <article-id pub-id-type="pmc">4243291</article-id>
      <article-id pub-id-type="publisher-id">64</article-id>
      <article-id pub-id-type="doi">10.1186/s40001-014-0064-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Human immunodeficiency virus-negative plasmablastic lymphoma in the neck: a rare case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Pengli</given-names>
          </name>
          <address>
            <email>liumin602822@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Min</given-names>
          </name>
          <address>
            <email>temuer2004@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Bailong</given-names>
          </name>
          <address>
            <email>bailong3385@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Bin</given-names>
          </name>
          <address>
            <email>binliu@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Yuhua</given-names>
          </name>
          <address>
            <email>yuhuazhou@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Dong</surname>
            <given-names>Lihua</given-names>
          </name>
          <address>
            <email>lijie200461@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Breast Surgery, The First Hospital, Jilin University, 71 Xinmin Street, Changchun, 130021 China </aff>
        <aff id="Aff2"><label/>Department of Radiation Oncology, The First Hospital, Jilin University, 71 Xinmin Street, Changchun, 130021 China </aff>
        <aff id="Aff3"><label/>Department of Hand Surgery, The First Hospital, Jilin University, 71 Xinmin Street, Changchun, 130021 China </aff>
        <aff id="Aff4"><label/>Department of Pathology, The First Hospital, Jilin University, 71 Xinmin Street, Changchun, 130021 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>22</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>19</volume>
      <issue>1</issue>
      <elocation-id>64</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Jiang et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Plasmablastic lymphoma (PBL) is an aggressive neoplasm exclusively occurring in AIDS patients. Recently, increasing cases of human immunodeficiency virus (HIV)-negative PBL have been reported. No standard therapy protocol is currently available since there is a great difference between PBL with and without HIV infection. Here, we present a rather rare case of HIV-negative PBL in the neck that dramatically responded to radiotherapy alone. Our case highlights the possibility of PBL in the neck and helps to expand our understanding of this separate lymphoma. The related literature review summarized the clinicopathological features and treatment status of HIV-negative PBL.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>HIV-negative</kwd>
        <kwd>Plasmablastic lymphoma</kwd>
        <kwd>Radiotherapy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Plasmablastic lymphoma (PBL) is a rare entity which mostly involves the oral cavity of human immunodeficiency virus (HIV)-positive individuals. Recently, increasing cases have been reported in HIV-negative patients [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR5">5</xref>]. Extraoral sites, such as the central nervous system, maxillary sinus, nasal cavity, gastrointestinal tract, liver, and retroperitoneal region, can also be involved [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR6">6</xref>-<xref ref-type="bibr" rid="CR9">9</xref>]. Many differences on the aspect of the clinicopathologic features and treatment response between HIV-positive and -negative cases have been revealed [<xref ref-type="bibr" rid="CR10">10</xref>]. Here, we present a PBL case in an immunocompetent woman for which radiotherapy alone provided a remarkable response without severe side effects or intensive chemotherapy.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 76-year-old female presented on October 22<sup>nd</sup>, 2013, with a history of a painless lump in the left region of the neck for about a month. She also complained of hoarseness and drinking cough for one week. She did not suffer from fever, night sweat, or significant weight loss. Her past history was unremarkable except for hypertension for about 5&#xA0;years without regular treatment and allergy to penicillin and cephalosporin. She denied any prior immunosuppressive conditions.</p>
      <p>On physical examination, her blood pressure was 146/70&#xA0;mmHg. The trachea shifted to the right side. A 5&#x2009;&#xD7;&#x2009;4&#xA0;cm firm mass was palpated in the lower left neck. No enlarged lymph nodes were palpable in the bilateral axilla and groin. Sternum tenderness was negative.</p>
      <p>Laboratory investigations demonstrated a normal complete blood cell count and a generally normal serum biochemical profile. The levels of IgG, IgA, IgM, and lactate dehydrogenase were normal. Erythrocyte sedimentation rate was elevated at 45&#xA0;mm/h (normal, &lt;20&#xA0;mm/h). &#x3B2;2-microglobulin was mildly elevated at 2.78&#xA0;mg/L (normal, &lt;1.8&#xA0;mg/L). Serum and urinary immunofixation electrophoresis were both negative. The content of &#x3BA; and &#x3BB; free light chain in the 24&#xA0;h urine was normal. The level of hepatitis B antigen was normal. Serum antibodies for hepatitis C, HIV, and syphilis were negative.</p>
      <p>Laryngoscopy showed left vocal cord paralysis. Ultrasound of the neck found a 50&#xA0;mm&#x2009;&#xD7;&#x2009;44&#xA0;mm heterogeneous hypoechoic mass in the left supraclavicular fossa which had no clear delineation with the left lobe of the thyroid. The patient then underwent a whole body PET/CT scan which demonstrated a hypermetabolic mass in the left supraclavicular fossa involving the left lobe of the thyroid (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). There was no other abnormal FDG uptake lesion. Biopsy of the lump revealed diffuse infiltration of medium to large atypical cells with round nuclei and prominent nucleolus (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>A). Neoplastic cells strongly expressed Mum-1 (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>B), CD 38 (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>C), CD 138 (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>D), and Ki-67 (80% expression, Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>E). The immunochemistry showed CK(&#x2013;), CD3(&#x2013;), CD7(&#x2013;), LCA(+), CD20(&#x2013;), pax-5(&#x2013;), CD30(&#x2013;), TdT(&#x2013;), and CD34(&#x2013;). In situ hybridization revealed negativity for Epstein-Barr virus-encoded small RNA (EBER) (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>F). Bone marrow aspiration did not reveal bone marrow involvement. Thus, the patient was diagnosed as PBL IA with an International Prognostic Index score of 1.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Whole body PET/CT scan evaluated the involvement.</bold> A hypermetabolic mass in the left supraclavicular fossa involved the left lobe of the thyroid. The large primary tumor compressed adjacent organs such as oropharynx, hypopharynx, larynx, trachea, and esophagus. No other abnormal FDG uptake lesions were found.</p></caption><graphic xlink:href="40001_2014_64_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Histopathologic results of biopsy specimen of the left supraclavicular mass. (A)</bold> Hematoxylin-eosin stained section (&#xD7;40) revealed that diffuse infiltration of medium to large atypical cells with round nuclei and prominent nucleolus. <bold>(B&#x2013;D)</bold> Immunochemistry examination for Mum-1, CD 38, and CD 138 were intensively positive for neoplastic cells (&#xD7;40). <bold>(E)</bold> Immunochemistry showed Ki-67 expressed in the nuclei of 80% of neoplastic cells (&#xD7;40). <bold>(F)</bold> In situ hybridization revealed negativity for Epstein-Barr virus-encoded small RNA (EBER) (&#xD7;40).</p></caption><graphic xlink:href="40001_2014_64_Fig2_HTML" id="MO2"/></fig></p>
      <p>Because of the patient&#x2019;s age, intensive chemotherapy was not performed. Instead, a vincristine and prednisone pretreatment regimen was given followed by 300&#xA0;mg cyclophosphamide and 10&#xA0;mg dexamethasone intravenously. The tumor had no response. However, the patient suffered from fungal infection. Due to the severe side effect, chemotherapy ceased and an effective antifungal treatment was administered along with best supportive care. In order to rapidly relieve the symptoms, she underwent radiation to the primary tumor by intensity-modulated radiotherapy (IMRT). After a dose of 28&#xA0;Gy/14 f, the tumor shrank significantly with a 71.4% response and all the discomforts disappeared (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>A,B). The radiotherapy plan was then adjusted and the lymphatic drainage area of the bilateral neck and the residual tumor were irradiated at a dose of 28&#xA0;of Gy/14 f by the RapidArc&#xAE; technique. After radiation with a dose of 56&#xA0;Gy/28 f, the tumor became smaller and the lesion exhibited an 87% response (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>C). To date, the patient is still alive.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Effect evaluation between pre-radiotherapy, radiotherapy with a dose of 28&#xA0;Gy/14 f, and after radiotherapy of 56&#xA0;Gy/28&#xA0;f. (A)</bold> Before radiotherapy the giant primary tumor compressed the trachea and esophagus and invaded the left lobe of the thyroid. <bold>(B)</bold> The tumor shrank greatly after irradiation of 28&#xA0;Gy/14&#xA0;f. <bold>(C)</bold> After radiotherapy of 56&#xA0;Gy/28 f, the tumor was minimal residual and the response was near complete remission.</p></caption><graphic xlink:href="40001_2014_64_Fig3_HTML" id="MO3"/></fig></p>
      <sec id="Sec3">
        <title>Discussion</title>
        <p>PBL was first described in the oral cavity of HIV-infected individuals in 1997 by Delecluse et al. [<xref ref-type="bibr" rid="CR11">11</xref>]. It was considered to have a strong correlation with HIV infection, accounting for about 2.6% of AIDS-related lymphoma [<xref ref-type="bibr" rid="CR12">12</xref>]. HIV-positive PBL is highly aggressive with a poor prognosis; its median survival after diagnosis is only 6&#xA0;months [<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref>]. Nowadays, increasing reports about extraoral PBL of immunocompetent patients have emerged. Research by Castillo et al. has shown that HIV-negative PBL has different clinicopathological features compared to HIV-positive PBL. HIV-positive PBL patients are younger and more commonly exhibit oral involvement and expression of CD20, CD56, and EBER. HIV-positive PBL has a higher response to chemotherapy and a relatively longer survival [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
        <p>HIV-negative PBL is a distinct entity which requires deep research. Because it is uncommon, we can only analyze and summarize sporadic cases. Epstein-Barr virus infection is more common in HIV-positive PBL [<xref ref-type="bibr" rid="CR15">15</xref>]. Usually, PBL individuals without HIV infection have an immunosuppression background. A report by Teruya-Feldstein et al. demonstrated that, among six HIV negative individuals, two cases had iatrogenic immunosuppression [<xref ref-type="bibr" rid="CR16">16</xref>]. One leg skin PBL patient had received a previous renal transplant [<xref ref-type="bibr" rid="CR17">17</xref>], and another suffering from ulcerative colitis had been administered azathioprine [<xref ref-type="bibr" rid="CR18">18</xref>]. In our case, negativity for EBER and the lack of an immunosuppressive condition are rather rare.</p>
        <p>Immunophenotypically, PBL strongly expresses CD38, CD138, and MUM1, negatively expresses CD20 and PAX5, and variably expresses CD79a, CD56, CD45, CD10, CD30, and EBV-EBER [<xref ref-type="bibr" rid="CR19">19</xref>]. In situ hybridization can detect the expression of EBER in 74% of cases [<xref ref-type="bibr" rid="CR20">20</xref>]. It is difficult to differentiate PBL from plasmablastic plasma cell myeloma especially in cases of extraoral sites without HIV infection. In such circumstances, clinical presentation plays an important role in differential diagnosis [<xref ref-type="bibr" rid="CR13">13</xref>]. PBL has no paraproteinemia, while the M-spike is essential for the diagnosis of plasmablastic plasma cell myeloma. Bone lytic lesions are rare in PBL except at the widely metastatic stage. However, pain or fracture caused by osteolytic bone destruction is the most common symptom for plasmablastic plasma cell myeloma [<xref ref-type="bibr" rid="CR13">13</xref>]. Usually, PBL has a higher Ki-67 index (&gt;85%) than plasmablastic plasma cell myeloma (5% to 60%) [<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR21">21</xref>]. Our case has the classic immunophenotypical and clinical features of PBL. Similar to the case documented by Lin et al. [<xref ref-type="bibr" rid="CR22">22</xref>], our case presented initially in a nodal site and had a dominant pattern of nodal involvement in an immunocompetent individual. Due to its rarity, there is no standard treatment for PBL. Current treatment strategies of PBL often mirror those from regimens for aggressive non-Hodgkin&#x2019;s lymphoma [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR23">23</xref>]. Intensive chemotherapy followed by consolidate radiotherapy can achieve an acceptable response for early stage patients with good performance [<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR15">15</xref>]. Saraceni et al. reported that an HIV-negative, stage IIE PBL patient attained complete remission of nearly 4&#xA0;years after six cycles of chemotherapy and irradiation of 45&#xA0;Gy [<xref ref-type="bibr" rid="CR6">6</xref>]. Similarly, in a case of HIV-negative PBL in the anorectal junction, three cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy and involved field irradiation brought a complete remission of nearly 5&#xA0;years [<xref ref-type="bibr" rid="CR15">15</xref>]. However, for elderly or poorly performing individuals, radiotherapy is usually initiated to rapidly relieve the discomfort. We must pay attention to side effects carefully. Thakral et al. reported on an 84-year-old female with PBL in the pelvis who suffered from bowel ischemia and infarction in the radiation field [<xref ref-type="bibr" rid="CR13">13</xref>]. Advanced radiotherapy technologies, such as IMRT and RapidArc&#xAE;, can maximize the dose to the tumor and minimize the dose to normal tissues. Thus, radiation-related toxicity can be greatly reduced. In our case, such advanced technologies were applied and the patient responded dramatically to radiotherapy with good tolerance.</p>
        <p>Recent studies have reported that bortezomib, a proteasome inhibitor, could achieve good effects in HIV-negative PBL, especially in recurrent or resistant cases after several lines of treatment [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR23">23</xref>]. The primary tumor was hypersensitive to bortezomib, which might cause tumor lysis syndrome [<xref ref-type="bibr" rid="CR23">23</xref>]. Thus, close surveillance and best care support should be given after bortezomib. Additionally, in HIV-positive PBL cases, bortezomib could also achieve a dramatic response [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
        <p>For HIV-negative PBL, autologous stem cell transplantation could be of benefit for short-term disease-free survival (up to 2&#xA0;years) [<xref ref-type="bibr" rid="CR25">25</xref>]. Other new drugs, such as brentuximab vedotin, have been reported to achieve response in CD30-positive cases [<xref ref-type="bibr" rid="CR26">26</xref>]. Research data showed that CD30 expression accounted for 30% of all PBL cases [<xref ref-type="bibr" rid="CR27">27</xref>-<xref ref-type="bibr" rid="CR29">29</xref>]. Holderness et al. revealed that in a CD30-positive, left supraclavicular PBL mass without HIV infection, brentuximab vedotin made the tumor shrink remarkably while multiple chemotherapy and irradiation had failed [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>HIV-negative PBL is a rare but distinct clinicopathological malignancy. There is no optimal treatment strategy. Our case supplemented valuable information for HIV-negative PBL in the neck. The effect of radiotherapy was verified in this case. Thus, radiotherapy might be the first option for elderly or poorly performing patients.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>EBER</term>
            <def>
              <p>Epstein-Barr virus-encoded small RNA</p>
            </def>
          </def-item>
          <def-item>
            <term>HIV</term>
            <def>
              <p>Human immunodeficiency virus</p>
            </def>
          </def-item>
          <def-item>
            <term>IMRT</term>
            <def>
              <p>Intensity-modulated radiotherapy</p>
            </def>
          </def-item>
          <def-item>
            <term>PBL</term>
            <def>
              <p>Plasmablastic lymphoma</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>PJ and ML were major contributors in writing the manuscript. BaL revised it critically. BiL reviewed PBL treatment. YZ reviewed the pathologic results of the patient. LD reviewed the literature and gave final approval of the version to be submitted. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The present study was supported by Science and Technology Department of Jilin Province (grant no.: 3D512J233428).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>LX</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>XH</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>ZY</given-names>
            </name>
          </person-group>
          <article-title>Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: a case report</article-title>
          <source>Diagn Pathol</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>51</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-7-51</pub-id>
          <pub-id pub-id-type="pmid">22568892</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoneyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kobara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morishita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Himoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A case of plasmablastic lymphoma of the liver without human immunodeficiency virus infection</article-title>
          <source>World J Gastroenterol</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>37</issue>
          <fpage>6299</fpage>
          <lpage>6303</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v19.i37.6299</pub-id>
          <pub-id pub-id-type="pmid">24115831</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Loo</surname>
              <given-names>BW</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Tillman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Natkunam</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Vaughan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Dorfman</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Goffinet</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Advani</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report</article-title>
          <source>Ann Hematol</source>
          <year>2003</year>
          <volume>82</volume>
          <issue>8</issue>
          <fpage>521</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="doi">10.1007/s00277-003-0684-3</pub-id>
          <pub-id pub-id-type="pmid">12783213</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marques</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lagos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Costa-Neves</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Gastric plasmablastic lymphoma in HIV-negative patient</article-title>
          <source>Rev Esp Enferm Dig</source>
          <year>2013</year>
          <volume>105</volume>
          <issue>3</issue>
          <fpage>166</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="doi">10.4321/S1130-01082013000300008</pub-id>
          <pub-id pub-id-type="pmid">23735024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saba</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Dang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Saba</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Janbain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maalouf</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Safah</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Bortezomib in plasmablastic lymphoma: a case report and review of the literature</article-title>
          <source>Onkologie</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>5</issue>
          <fpage>287</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="doi">10.1159/000350325</pub-id>
          <pub-id pub-id-type="pmid">23689224</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saraceni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Agostino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cornfield</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review</article-title>
          <source>Springerplus</source>
          <year>2013</year>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>142</fpage>
          <pub-id pub-id-type="doi">10.1186/2193-1801-2-142</pub-id>
          <pub-id pub-id-type="pmid">23667804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jae Myung</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Joung Il</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kwang Ro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sung Won</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hyun Phil</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jae Jin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gyo Young</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A case report with plasmablastic lymphoma of the jejunum</article-title>
          <source>J Korean Med Sci</source>
          <year>2010</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>496</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.3346/jkms.2010.25.3.496</pub-id>
          <pub-id pub-id-type="pmid">20191056</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H-W</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>J-Z</given-names>
            </name>
            <name>
              <surname>Jiang-Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma of the small intestine: case report and literature review</article-title>
          <source>World J Gastroenterol</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>45</issue>
          <fpage>6677</fpage>
          <lpage>6681</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v18.i45.6677</pub-id>
          <pub-id pub-id-type="pmid">23236245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tille</surname>
              <given-names>J-C</given-names>
            </name>
            <name>
              <surname>Pelte</surname>
              <given-names>M-F</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>P-Y</given-names>
            </name>
            <name>
              <surname>McKee</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma clinically presenting in the urinary tract</article-title>
          <source>Ann Diagn Pathol</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>219</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anndiagpath.2011.02.002</pub-id>
          <pub-id pub-id-type="pmid">21531157</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castillo</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Winer</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Stachurski</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jabbour</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Milani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Colvin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Butera</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <article-title>Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma</article-title>
          <source>Leuk Lymphoma</source>
          <year>2010</year>
          <volume>51</volume>
          <issue>11</issue>
          <fpage>2047</fpage>
          <lpage>2053</lpage>
          <pub-id pub-id-type="doi">10.3109/10428194.2010.516040</pub-id>
          <pub-id pub-id-type="pmid">20919850</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delecluse</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Anagnostopoulos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dallenbach</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hummel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marafioti</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Huhn</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schmidt-Westhausen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reichart</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <issue>4</issue>
          <fpage>1413</fpage>
          <lpage>1420</lpage>
          <pub-id pub-id-type="pmid">9028965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carbone</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaidano</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gloghini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferlito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rinaldo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma</article-title>
          <source>Ann Otol Rhinol Laryngol</source>
          <year>1999</year>
          <volume>108</volume>
          <issue>1</issue>
          <fpage>95</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1177/000348949910800115</pub-id>
          <pub-id pub-id-type="pmid">9930548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thakral</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gajra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hutchison</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Ravizzini</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Vajpayee</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma in an immunocompetent patient</article-title>
          <source>J Clin Oncol</source>
          <year>2009</year>
          <volume>27</volume>
          <issue>25</issue>
          <fpage>e78</fpage>
          <lpage>e81</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2009.22.2208</pub-id>
          <pub-id pub-id-type="pmid">19581534</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chetty</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hlatswayo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Muc</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sabaratnam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gatter</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma in HIV+ patients: an expanding spectrum</article-title>
          <source>Histopathology</source>
          <year>2003</year>
          <volume>42</volume>
          <issue>6</issue>
          <fpage>605</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2559.2003.01636.x</pub-id>
          <pub-id pub-id-type="pmid">12786898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brahmania</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sylwesterowic</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Leitch</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case report</article-title>
          <source>J Med Case Rep</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>168</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-1947-5-168</pub-id>
          <pub-id pub-id-type="pmid">21539737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teruya-Feldstein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chiao</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Filippa</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Comenzo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Portlock</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Noy</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and-negative patients</article-title>
          <source>Ann Oncol</source>
          <year>2004</year>
          <volume>15</volume>
          <issue>11</issue>
          <fpage>1673</fpage>
          <lpage>1679</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/mdh399</pub-id>
          <pub-id pub-id-type="pmid">15520070</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicol</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Boye</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Carsuzaa</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Feier</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Collet Villette</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Xerri</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Grob</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Richard</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Post-transplant plasmablastic lymphoma of the skin</article-title>
          <source>Br J Dermatol</source>
          <year>2003</year>
          <volume>149</volume>
          <issue>4</issue>
          <fpage>889</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2133.2003.05544.x</pub-id>
          <pub-id pub-id-type="pmid">14616390</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fend</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Quintanilla-Martinez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kingma</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Sorbara</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Raffeld</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Epstein-Barr virus-positive primary gastrointestinal Hodgkin&#x2019;s disease: association with inflammatory bowel disease and immunosuppression</article-title>
          <source>Am J Surg Pathol</source>
          <year>2000</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>66</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200001000-00008</pub-id>
          <pub-id pub-id-type="pmid">10632489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsi</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Lorsbach</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Fend</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dogan</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma and related disorders</article-title>
          <source>Am J Clin Pathol</source>
          <year>2011</year>
          <volume>136</volume>
          <issue>2</issue>
          <fpage>183</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.1309/AJCPV1I2QWKZKNJH</pub-id>
          <pub-id pub-id-type="pmid">21757592</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castillo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pantanowitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dezube</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases</article-title>
          <source>Am J Hematol</source>
          <year>2008</year>
          <volume>83</volume>
          <issue>10</issue>
          <fpage>804</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="doi">10.1002/ajh.21250</pub-id>
          <pub-id pub-id-type="pmid">18756521</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teruya-Feldstein</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Diffuse large B-cell lymphomas with plasmablastic differentiation</article-title>
          <source>Curr Oncol Rep</source>
          <year>2005</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>357</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1007/s11912-005-0062-5</pub-id>
          <pub-id pub-id-type="pmid">16091196</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Quiery</surname>
              <given-names>AT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Prichard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schuerch</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2004</year>
          <volume>128</volume>
          <issue>5</issue>
          <fpage>581</fpage>
          <lpage>584</lpage>
          <pub-id pub-id-type="pmid">15086296</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lipstein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Montanari</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Paoluzzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bongero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bhagat</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma</article-title>
          <source>Clin Lymphoma Myeloma Leuk</source>
          <year>2010</year>
          <volume>10</volume>
          <issue>5</issue>
          <fpage>E43</fpage>
          <lpage>E46</lpage>
          <pub-id pub-id-type="doi">10.3816/CLML.2010.n.074</pub-id>
          <pub-id pub-id-type="pmid">21856550</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bose</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gandhi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ghabach</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ozer</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib</article-title>
          <source>Eur J Haematol</source>
          <year>2009</year>
          <volume>82</volume>
          <issue>6</issue>
          <fpage>490</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0609.2009.01235.x</pub-id>
          <pub-id pub-id-type="pmid">19220417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ayala</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Field</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ochoa-Bayona</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bello</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Chervenick</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cultrera</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Baz</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Kharfan-Dabaja</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Raychaudhuri</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sotomayor</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sokol</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review</article-title>
          <source>Leuk Res</source>
          <year>2011</year>
          <volume>35</volume>
          <issue>12</issue>
          <fpage>1571</fpage>
          <lpage>1577</lpage>
          <pub-id pub-id-type="doi">10.1016/j.leukres.2011.06.023</pub-id>
          <pub-id pub-id-type="pmid">21752466</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holderness</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Danilov</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>12</issue>
          <fpage>e197</fpage>
          <lpage>e199</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2012.46.9593</pub-id>
          <pub-id pub-id-type="pmid">23509308</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colomo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Loong</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rives</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pittaluga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-Guillermo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ojanguren</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Romagosa</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities</article-title>
          <source>Am J Surg Pathol</source>
          <year>2004</year>
          <volume>28</volume>
          <issue>6</issue>
          <fpage>736</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pas.0000126781.87158.e3</pub-id>
          <pub-id pub-id-type="pmid">15166665</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vega</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Udden</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Cho-Vega</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Vilchez</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>McGregor</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles</article-title>
          <source>Mod Pathol</source>
          <year>2005</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>806</fpage>
          <lpage>815</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3800355</pub-id>
          <pub-id pub-id-type="pmid">15578069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folk</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Abbondanzo</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Childers</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Foss</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma: a clinicopathologic correlation</article-title>
          <source>Ann Diagn Pathol</source>
          <year>2006</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>8</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anndiagpath.2005.07.009</pub-id>
          <pub-id pub-id-type="pmid">16414538</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
